The global primary biliary cholangitis therapeutics market was valued at $684 million in 2022, and is projected to reach $1.4 billion by 2032, growing at a CAGR of 7.1% from 2023 to 2032.
Hepatitis C is a viral infection that causes inflammation of the liver, which can lead to severe liver damage. Infections caused by the blood-borne virus hepatitis C virus ...
The global pharmaceutical primary packaging label market size was valued at $2,377.83 million in 2020, and is projected to reach $4,762.81 million by 2030 registering a CAGR of ...
